vs

Side-by-side financial comparison of FORWARD AIR CORP (FWRD) and INNOSPEC INC. (IOSP). Click either name above to swap in a different company.

FORWARD AIR CORP is the larger business by last-quarter revenue ($631.2M vs $455.6M, roughly 1.4× INNOSPEC INC.). INNOSPEC INC. runs the higher net margin — 10.4% vs -4.5%, a 14.9% gap on every dollar of revenue. On growth, FORWARD AIR CORP posted the faster year-over-year revenue change (-0.3% vs -2.4%). Over the past eight quarters, FORWARD AIR CORP's revenue compounded faster (7.9% CAGR vs -4.6%).

Forward Air Corp is a leading North American asset-light logistics and transportation provider. It offers core services including expedited less-than-truckload freight delivery, final-mile logistics, intermodal transport, warehousing, and supply chain solutions, serving key sectors such as e-commerce, retail, manufacturing, and automotive across the U.S., Canada, and Mexico.

Innospec Inc., formerly known as Octel Corporation and Associated Octel Company, Ltd., is an American specialty chemical company. It comprises three business units:The Performance Chemicals business trades in the personal care, home care, agrochemical, mining and industrial markets. The Fuel Specialties business specializes in manufacturing and supplying fuel additives. The Oilfield Services business supplies drilling, completion and production chemicals.

FWRD vs IOSP — Head-to-Head

Bigger by revenue
FWRD
FWRD
1.4× larger
FWRD
$631.2M
$455.6M
IOSP
Growing faster (revenue YoY)
FWRD
FWRD
+2.1% gap
FWRD
-0.3%
-2.4%
IOSP
Higher net margin
IOSP
IOSP
14.9% more per $
IOSP
10.4%
-4.5%
FWRD
Faster 2-yr revenue CAGR
FWRD
FWRD
Annualised
FWRD
7.9%
-4.6%
IOSP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FWRD
FWRD
IOSP
IOSP
Revenue
$631.2M
$455.6M
Net Profit
$-28.3M
$47.4M
Gross Margin
28.0%
Operating Margin
-0.5%
10.3%
Net Margin
-4.5%
10.4%
Revenue YoY
-0.3%
-2.4%
Net Profit YoY
22.2%
167.3%
EPS (diluted)
$-0.90
$1.90

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FWRD
FWRD
IOSP
IOSP
Q4 25
$631.2M
$455.6M
Q3 25
$631.8M
$441.9M
Q2 25
$618.8M
$439.7M
Q1 25
$613.3M
$440.8M
Q4 24
$632.8M
$466.8M
Q3 24
$655.9M
$443.4M
Q2 24
$643.7M
$435.0M
Q1 24
$541.8M
$500.2M
Net Profit
FWRD
FWRD
IOSP
IOSP
Q4 25
$-28.3M
$47.4M
Q3 25
$-16.3M
$12.9M
Q2 25
$-12.6M
$23.5M
Q1 25
$-50.6M
$32.8M
Q4 24
$-36.4M
$-70.4M
Q3 24
$-73.4M
$33.4M
Q2 24
$-645.4M
$31.2M
Q1 24
$-61.7M
$41.4M
Gross Margin
FWRD
FWRD
IOSP
IOSP
Q4 25
28.0%
Q3 25
26.4%
Q2 25
28.0%
Q1 25
28.4%
Q4 24
29.2%
Q3 24
28.0%
Q2 24
29.2%
Q1 24
31.1%
Operating Margin
FWRD
FWRD
IOSP
IOSP
Q4 25
-0.5%
10.3%
Q3 25
2.4%
1.3%
Q2 25
3.2%
7.8%
Q1 25
0.8%
9.6%
Q4 24
12.0%
8.8%
Q3 24
3.5%
10.3%
Q2 24
-170.2%
9.4%
Q1 24
-12.1%
10.1%
Net Margin
FWRD
FWRD
IOSP
IOSP
Q4 25
-4.5%
10.4%
Q3 25
-2.6%
2.9%
Q2 25
-2.0%
5.3%
Q1 25
-8.3%
7.4%
Q4 24
-5.8%
-15.1%
Q3 24
-11.2%
7.5%
Q2 24
-100.3%
7.2%
Q1 24
-11.4%
8.3%
EPS (diluted)
FWRD
FWRD
IOSP
IOSP
Q4 25
$-0.90
$1.90
Q3 25
$-0.52
$0.52
Q2 25
$-0.41
$0.94
Q1 25
$-1.68
$1.31
Q4 24
$-1.69
$-2.80
Q3 24
$-2.66
$1.33
Q2 24
$-23.47
$1.24
Q1 24
$-2.81
$1.65

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FWRD
FWRD
IOSP
IOSP
Cash + ST InvestmentsLiquidity on hand
$106.0M
$292.5M
Total DebtLower is stronger
$1.7B
Stockholders' EquityBook value
$113.3M
$1.3B
Total Assets
$2.7B
$1.8B
Debt / EquityLower = less leverage
14.89×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FWRD
FWRD
IOSP
IOSP
Q4 25
$106.0M
$292.5M
Q3 25
$140.4M
$270.8M
Q2 25
$95.1M
$266.6M
Q1 25
$116.3M
$299.8M
Q4 24
$104.9M
$289.2M
Q3 24
$136.6M
$303.8M
Q2 24
$84.9M
$240.2M
Q1 24
$152.0M
$270.1M
Total Debt
FWRD
FWRD
IOSP
IOSP
Q4 25
$1.7B
Q3 25
$1.7B
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
$1.7B
Stockholders' Equity
FWRD
FWRD
IOSP
IOSP
Q4 25
$113.3M
$1.3B
Q3 25
$139.8M
$1.3B
Q2 25
$151.8M
$1.3B
Q1 25
$154.6M
$1.3B
Q4 24
$201.7M
$1.2B
Q3 24
$226.1M
$1.2B
Q2 24
$283.8M
$1.2B
Q1 24
$926.1M
$1.2B
Total Assets
FWRD
FWRD
IOSP
IOSP
Q4 25
$2.7B
$1.8B
Q3 25
$2.8B
$1.8B
Q2 25
$2.8B
$1.8B
Q1 25
$2.8B
$1.8B
Q4 24
$2.8B
$1.7B
Q3 24
$3.1B
$1.8B
Q2 24
$3.1B
$1.7B
Q1 24
$4.0B
$1.7B
Debt / Equity
FWRD
FWRD
IOSP
IOSP
Q4 25
14.89×
Q3 25
12.05×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
1.81×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FWRD
FWRD
IOSP
IOSP
Operating Cash FlowLast quarter
$61.4M
Free Cash FlowOCF − Capex
$46.8M
FCF MarginFCF / Revenue
10.3%
Capex IntensityCapex / Revenue
1.3%
3.2%
Cash ConversionOCF / Net Profit
1.30×
TTM Free Cash FlowTrailing 4 quarters
$88.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FWRD
FWRD
IOSP
IOSP
Q4 25
$61.4M
Q3 25
$52.7M
$39.3M
Q2 25
$9.3M
Q1 25
$27.6M
$28.3M
Q4 24
$-23.2M
$25.7M
Q3 24
$51.2M
$73.5M
Q2 24
$-45.2M
$4.7M
Q1 24
$-51.7M
$80.6M
Free Cash Flow
FWRD
FWRD
IOSP
IOSP
Q4 25
$46.8M
Q3 25
$48.6M
$25.0M
Q2 25
$-3.7M
Q1 25
$15.7M
$19.9M
Q4 24
$-30.5M
$13.6M
Q3 24
$40.7M
$65.8M
Q2 24
$-59.6M
$-6.2M
Q1 24
$-56.7M
$69.9M
FCF Margin
FWRD
FWRD
IOSP
IOSP
Q4 25
10.3%
Q3 25
7.7%
5.7%
Q2 25
-0.8%
Q1 25
2.6%
4.5%
Q4 24
-4.8%
2.9%
Q3 24
6.2%
14.8%
Q2 24
-9.3%
-1.4%
Q1 24
-10.5%
14.0%
Capex Intensity
FWRD
FWRD
IOSP
IOSP
Q4 25
1.3%
3.2%
Q3 25
0.7%
3.2%
Q2 25
0.8%
3.0%
Q1 25
1.9%
1.9%
Q4 24
1.1%
2.6%
Q3 24
1.6%
1.7%
Q2 24
2.2%
2.5%
Q1 24
0.9%
2.1%
Cash Conversion
FWRD
FWRD
IOSP
IOSP
Q4 25
1.30×
Q3 25
3.05×
Q2 25
0.40×
Q1 25
0.86×
Q4 24
Q3 24
2.20×
Q2 24
0.15×
Q1 24
1.95×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FWRD
FWRD

Omni Logistics Segment$359.8M57%
Network$183.9M29%
Intermodal Segment$50.2M8%
Truckload$41.6M7%

IOSP
IOSP

Refinery And Performance$147.0M32%
Personal Care$99.7M22%
Oilfield Services$93.1M20%
Other Fuel Specialties$47.1M10%
Other Performance Chemicals$40.0M9%
Home Care$28.7M6%

Related Comparisons